Through an inducible transgenic approach for SMN induction in SMA mice, it has been confirmed that systemic induction of high levels of SMN at an early stage is essential not only for lifespan extension but also for improving the neuromuscular phenotype.6 This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.